NPRA approves shelf-life extension for Pfizer, Sinovac vaccines

Published: Nov 16, 2021 10:02 AM | Updated: Nov 16, 2021 10:17 AM

The National Pharmaceutical Regulatory Agency (NPRA) has approved shelf-life extensions for Covid-19 vaccines developed by Sinovac and Pfizer-BioNTech.

Health director-general Dr Noor Hisham Abdullah said the decision was made after Pfizer (Malaysia) Sdn Bhd and Sinovac’s local partner Pharmaniaga Lifescience Shd Bhd both submitted additional stability data for their respective vaccines.

The shelf life for Sinovac’s Coronavac vaccine is...

YOURSAY | Give more options to those taking booster shots

Pfizer's Covid-19 booster preferred due to higher effectiveness, says MOH

Warning of ‘early signs’, DG says now is time to prevent Covid-19 spike

Annuar issues 'gentle reminder' to unvaccinated artistes

Vaccination for children below 12 to begin next year

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: